FDAFDA · Food and drugs·Recall number D-0327-2024
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
Published February 28, 2024 · Recall initiated: February 13, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out-of-specification test results.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- OSELTAMIVIR PHOSPHATE
- Manufacturer
- Amneal Pharmaceuticals of New York, LLC
- Distributor
- Nationwide in the USA
- UPC
- 0369238127362
- Lot
- Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.